Speaker: Dr Marcin Plech, University of Edinburgh
Title: Mapping gain- and loss-of-function variants in CDC42, a Rho-family switch GTPase
Speaker Bio: Marcin Plech is a postdoctoral researcher at the University of Edinburgh, working in the laboratories of Greg Kudla and Joseph Marsh.
He obtained his PhD from Jagiellonian University in Kraków, where he investigated the consequences of mutational load, inbreeding depression and genetic robustness using yeast as a model organism.
His current research focuses on understanding the functional consequences of genetic variation associated with human Mendelian disorders. Using yeast-based deep mutational scanning, he designs tailored, multi-condition screens to investigate how mutations affect protein function across different expression levels and experimental contexts. By examining variant effects under diverse conditions, his work aims to provide deeper insights into the molecular mechanisms underlying genetic disorders and generate comprehensive functional datasets to support clinical variant interpretation.
Abstract: Missense variants in CDC42, an essential Rho-family GTPase, cause a heterogeneous spectrum of developmental, immunological and haematological disorders. Their functional interpretation is complicated by the diverse ways in which variants disrupt its molecular switch cycle. We performed deep mutational scanning of human CDC42 in yeast across eight expression and stress conditions, generating a near-complete fitness map of missense variants.
Variant effects resolved into four broad classes: toxic gain of function, conditionally toxic gain of function, partial or complete loss of function, and wild-type-like. These classes reflected established biochemical mechanisms, including impaired GTP hydrolysis, accelerated nucleotide cycling, disrupted effector binding and dominant-negative activity. A subset of variants was toxic at high expression but tolerated at low expression, with affected residues clustering near the GTPase–GAP interface, suggesting disruption of nucleotide-cycle regulation.
Functional scores distinguished pathogenic from benign variants, and sensitised conditions enabled calibration to ACMG/AMP functional-evidence levels for more than 90% of variants. CDC42 scores also informed the interpretation of disease variants in RAC1–3 and, more weakly, across the Ras GTPase superfamily, with transfer strongest at conserved positions. Together, these findings illustrate how testing variants across multiple contexts can reveal mechanisms of dysfunction and support clinical interpretation within and across related proteins.